General Information of DTT (ID: TTXMY0J)

DTT Name Pancreatic triacylglycerol lipase (PNLIP) DTT Info
Gene Name PNLIP

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
2 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dalbavancin DMGMNH3 Bacterial infection 1A00-1C4Z Approved [1]
Orlistat DMRJSP8 Obesity 5B81 Approved [2]
------------------------------------------------------------------------------------
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pancrecarb DMOML9Q Pancreatic malfunction DC30-DC3Z NDA filed [3]
Liprotamase DMNF4UH Cystic fibrosis CA25 Phase 3 [4]
MS-1819 DM35YFC Exocrine pancreatic insufficiency DC35.1 Phase 1/2 [5]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AZM-131 DMLCSRF Obesity 5B81 Terminated [6]
------------------------------------------------------------------------------------
5 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
(Hydroxyethyloxy)Tri(Ethyloxy)Octane DMY6FUD Discovery agent N.A. Investigative [7]
B-Nonylglucoside DM48VJR Discovery agent N.A. Investigative [8]
B-Octylglucoside DMMO75G Discovery agent N.A. Investigative [7]
Daio-Orengedokuto (DOT) DM3M652 Discovery agent N.A. Investigative [9]
METHOXYUNDECYLPHOSPHINIC ACID DMY0O7X Discovery agent N.A. Investigative [8]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Pfizer. Product Development Pipeline. March 31 2009.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
3 Clinical pipeline report, company report or official report of Digestive Care.
4 Clinical pipeline report, company report or official report of Anthera Pharmaceuticals.
5 Clinical pipeline report, company report or official report of AzurRx.
6 US patent application no. 7217,697, Glucopyranosyloxypyrazole derivative medicinal composition containing the same medicinal use thereof and intermediate therefor.
7 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
8 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
9 Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol Pharm Bull. 2002 Nov;25(11):1442-5.